The answer so far

GHK-Cu is a copper-binding peptide found in some skin-care products. GLOW and KLOW are seller-defined names for mixtures that commonly include GHK-Cu and other peptides. People may look at them for skin appearance, hair or recovery, but a topical serum and an injectable blend are different products, and their results cannot be assumed to match.12

On this page
  1. Start with what you are looking for
  2. What is in each name?
  3. What is each ingredient supposed to contribute?
  4. Does KLOW reduce injection-site reactions?
  5. Does a serum study tell me what an injected blend does?
  6. A useful next question
  7. Sources
LINKED BUILDING BLOCKSAmino acids joined into a chainSequence and structure both matter
Conceptual schematic. Simplified and not to scale; not a scan, microscopy image or validated simulation.

Start with what you are looking for

If your question is about the look or feel of skin, you may encounter a GHK-Cu serum alongside claims for GLOW and KLOW. If your question is recovery, you may see the same blends discussed in a different context. The intended goal is useful to understand; it is not itself evidence that a product achieves it. See the GHK-Cu profile and the route comparison.

For an everyday skin-care question, see what to expect from a copper-peptide serum.

For the proposed role of each ingredient and the evidence behind it, see how GLOW and KLOW are meant to work.1

What is in each name?

GHK-Cu is one peptide bound to copper; a serum contains a complete cosmetic formula, not just that ingredient. One GLOW product example lists GHK-Cu, BPC-157 and TB-500; a separate published description of KLOW adds KPV to those three. Names and amounts are not standardised, so check the exact label: another product can differ. Read the GLOW and KLOW profiles.23

A 2026 Australian TGA advisory reported no detectable TB-500 in tested Synedica KLOW 80 mg and BARBIE KLOW 100 mg products, although their labels listed it; those labels also listed B12. This finding is about those tested products, not every product called KLOW. The TGA advises people with Synedica-branded peptide products to stop using them and seek health advice if concerned; see the KLOW profile for the advisory and disposal context.11

Three names, different questionsIllustrative examples: blend names are not standardised; always check the exact product.
  • GHK-Cu serumA finished topical formula containing a copper peptide.
  • GLOWOne common seller description: GHK-Cu, BPC-157 and TB-500.
  • KLOWSome sellers describe the same three ingredients with KPV added.
  • What is known?A topical study or a study of one ingredient does not establish the effect of a whole blend.

What is each ingredient supposed to contribute?

GHK-Cu is studied in cosmetic and skin-related contexts. BPC-157 is investigated in animal models of tissue injury; TB-500 is a fragment related to a longer protein studied in repair. Research on the longer protein does not establish the fragment’s effects. KPV has been studied in inflammatory pathways in cells and mice. These are rationales for research, not proof that the ingredients work together in people.456

Does KLOW reduce injection-site reactions?

Some people hope the added KPV will make a GLOW-like blend less irritating at the injection site. We found no controlled human comparison establishing that effect; individual accounts are not a reliable measure of effectiveness or safety. A reaction can have different causes. Our practical guide to injection-site reactions explains what to notice and when to seek help.

Painful, hot and swollen skin needs urgent medical advice. If the lips, mouth, tongue or throat suddenly swell, or breathing becomes difficult, call local emergency services immediately; do not wait to decide which ingredient caused the reaction.57910

Does a serum study tell me what an injected blend does?

No. A topical product is formulated for application to skin; injection bypasses that barrier and raises different exposure and product-quality questions. A small study after laser treatment and a small eyebrow study examined specific topical regimens, not these blends or injections. Neither shows that injection works better, or that results transfer between products. For an eyebrow-versus-scalp comparison, see what the hair studies actually tested.18

A useful next question

Check the exact product and its route, then ask what outcome was measured in people using that same formulation. Certificates and testimonials cannot establish that a mixture works. For a skin serum, read the product’s directions; for questions about a particular product or a reaction, a pharmacist or clinician can help. Continue with how to assess claims for a peptide stack or product identity and storage claims.6

Sources, kept close.

Selected supporting sources; this is not a complete literature review.

  1. Effects of Topical Copper Tripeptide Complex on CO2 Laser–Resurfaced SkinArchives of Facial Plastic Surgery · Randomized human studyAccess checked 2026-11-04 · Source date: 2006 · Thirteen completers after laser treatment, with 12-week follow-up; abstract accessible. The small study cannot establish effects in ordinary skin or injected products.
  2. KLOW and GLOW peptide blends: what is in each vialCondor Research (seller) · Seller description; not clinical evidenceAccessed 2026-11-05 · Source date: 2026-10
  3. Four ingredients in the KLOW peptide stackKLOW Medicine · Published research commentary describing a purported blend; not independent product verificationAccessed 2026-11-03
  4. Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safetyPeer-reviewed systematic review / PubMed · Systematic review; very low certainty evidenceAccessed 2026-11-03 · Source date: 2026
  5. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammationGastroenterology / PubMed · Primary preclinical study of human cell lines and mouse models; 2008Accessed 2026-11-04
  6. Certain bulk drug substances that may present significant safety risksU.S. Food and Drug Administration · Regulator recordAccessed 2026-11-03
  7. CellulitisNHS · Official clinical guidanceAccessed 2026-11-07
  8. The Efficacy of 2% Copper Peptide (GHK-Cu) Serum for Eyebrow HypotrichosisProcedia of Multidisciplinary Research · Randomized split-face human studyAccess checked 2026-11-06 · Source date: 2026-05-22 · Published article checked 2026-11-06: 18 healthy adults, one eyebrow per product, 1 cm², 12 weeks. The protocol excluded adverse patch-test reactions; authors stated no allergic reactions occurred during testing. No funding source stated; no scalp or injection results.
  9. Discussion of GLOW reactions and KLOW (unverified individual comments)Reddit, r/BiohackingU · Anecdotal discussion; not clinical evidenceAccessed 2026-11-05
  10. AnaphylaxisNHS · Official clinical guidanceAccess checked 2026-11-07 · General emergency signs; page reviewed June 2023 with review due June 2026. Emergency numbers depend on location.
  11. TGA testing finds unapproved peptides do not contain what their labels claimTherapeutic Goods Administration, Australia · Australian regulator safety advisoryAccess checked 2026-11-07 · Published 5 November 2026; findings concern the tested Synedica products, not every product bearing a similar name.